Latest updates on private equity sector in Central and Eastern Europe region
MidEuropa-Backed Diagnostyka Makes Successful IPO Debut in Poland
In a significant move for the Polish market, Diagnostyka, a leading diagnostic service provider, made its stock market debut on 7th February 2025. The initial public offering (IPO) marked a successful fundraising round, raising more than €400m in gross proceeds, priced at PLN105 (€25) per share.
The IPO stands among the largest private equity-backed public exits in recent years, reinforcing MidEuropa's dominance in European healthcare. Since acquiring Diagnostyka in 2011, MidEuropa has fueled its growth through 120 acquisitions, leading to an IPO valuation of over €1bn.
MidEuropa's investors received over €400m from the IPO, marking a significant return on their investment. The successful IPO also highlights the growing interest in the Polish market, with several private equity funds successfully raising capital focused on Polish companies in recent years, often targeting sectors like technology, healthcare, and manufacturing.
Meanwhile, Morphosis Capital, a private equity firm that focuses on sectors such as healthcare, B2B services, consumer products and retail, and niche manufacturing, launched its second fund, Morphosis Capital Fund II. The fund secured over €100m in committed capital, making it double the size of its predecessor.
Morphosis Capital aims to invest in small and medium-sized enterprises (SMEs) across Romania and neighbouring regions. The fund, like the INVL Private Equity Fund II, will target companies with strong growth potential and will invest across Lithuania, Latvia, Estonia, Poland, Romania, and the broader EU.
The INVL Private Equity Fund II, which surpassed its initial €250m target, recently completed the first closing, raising €305m. This makes it the largest private equity vehicle in the Baltics. The fund will focus on investing in companies with strong growth potential and will follow a similar strategy to its predecessor, which has been successful in the region.
The activity in the region reflects the growing interest in venture capital and private equity, with funds focusing on tech startups, fintech, renewable energy, and more. While IPOs are less frequent, they are gradually increasing as capital markets mature. For the most current and specific examples from 2024-2025, it is recommended to check regional financial news portals, stock exchange announcements (Warsaw, Nasdaq Baltic), and reports from private equity associations in these countries.
- MidEuropa, a dominant force in European healthcare, raised more than €400m through Diagnostyka's IPO, marking a successful exit for private equity-backed GP investments.
- Morphosis Capital, another private equity firm, launched its second fund, Morphosis Capital Fund II, securing over €100m in committed capital, aiming to invest in SMEs across Romania and neighboring regions.
- The INVL Private Equity Fund II, the largest private equity vehicle in the Baltics, recently surpassed its initial €250m target, focusing on investing in companies with strong growth potential and following a similar strategy to its predecessor.
- As capital markets mature, IPOs are gradually increasing in the region, with venture capital and private equity firms focusing on tech startups, fintech, renewable energy, and more, making 2024-2025 an active period for these investments.
